SURMOUNT-1 Trial (Tirzepatide for Weight Loss in Adults with Obesity): Duration: 72 weeks (18 months) Participants: Adults with BMI 30+ or 27+ with comorbidities Intervention: Weekly tirzepatide injections + lifestyle counseling Average weight loss results in clinical trials of FDA-approved tirzepatide: Dose-dependent response: Higher doses produced greater weight loss Average range across doses: 15-22% of body weight over 72 weeks For context: A 230-pound person losing 20% would lose approximately 46 pounds Placebo (lifestyle alone): Approximately 3% of body weight Key findings: Weight loss was gradual, not rapid (took a full 72 weeks to reach maximum) Higher doses produced more weight loss (dose-response relationship) Almost everyone lost some weight, but the amount varied dramatically Lifestyle counseling was included (not medication alone) Individual Variation: Why Results Differ The clinical trial averages mask huge individual variation

Once the patient is released to go home, they wear a tight compression garment to try and promote skin contraction and help obliterate the potential space where the fat once existed
Garcinia Cambogia+L-Carnitina x 100Und S/ 36.90 Informacin del producto Presentacin Cpsula Composicin Mezcla en polvo para bebida instantnea a base naranja, caf verde, garcinia cambogia, hojas de stevia y L-carnitina
Tools like DEXA scans or bioimpedance can track lean mass loss, not just weight
If youd like to make an appointment for weight loss support, please book your appointment online or call your local OnePeak Medical clinic